New office space coming on stream, survey finds

Article Abstract:

A survey conducted by Royal LePage Commercial Inc. revealed that an estimated 1.9 million sq ft of new office space will be available nationwide before the end of 1998. The survey found out that although most of the new office space under constructions are being built under contract for certain tenants, there are projects that contain speculative space that developers expect to lease before completion of construction. Another 700,000-sq-ft of office space is under construction, though it will not be finished within 1998. Real estate developers also are trying to prelease another 13 office projects nationwide, with about 5 million sq ft of space.

Comment:

Survey reveals that an estimated 1.9 mil sq ft of new office space will be available nationwide before the end of 1998

Science & research, Commercial and Institutional Building Construction, Office Buildings, Office construction, Article

---

U.K. drug firm rescues troubled Hyal

Article Abstract:

Hyal Pharmaceutical Corp has escaped bankruptcy by agreeing to be sold to UK-based SkyePharma PLC for $4.1 million in stock. Under the terms of the agreement, SkyePharma will buy $3.4 million of Hyal debentures by Jul 30, 1999, while the remaining $688,096 will be bought once Hyal's topical gel product obtains approval from the US Food and Drug Administration (FDA). The deal also calls for SkyePharma to buy Hyal's 31.8 million common shares outstanding for $0.07 each if the FDA approves Solarese by the end of 2000.

Asset sales & divestitures, Acquisitions & mergers, Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Hyal Pharmaceutical Corp.

---

Biotech firm prepares for pandemic

Article Abstract:

William Gastle, chief executive officer of Microbix Biosystems Inc., highlights the lack of public awareness about bird flu, its implications, and prevention methods in case of an outbreak. Gastle also discusses the measures that the company is taking to handle the situation, if it arises.

Executive changes & profiles, Drugs, Care and treatment, Officials and employees, Biotechnology industry, Biotechnology industries, Prevention, Interview, Control, Epidemics, Avian influenza, Gastle, William, Microbix Biosystems Inc.

Similar abstracts:

• Abstracts: Apple raises curtain on movies service. ATI finds a friend in AMD
• Abstracts: Onex plans pledge on airline jobs. Chain's rescue plan failed to flower. Blue-chip Canada explores trust spinoffs
• Abstracts: Former executive says Shell loosened reserve guidelines. TransAlta, Chilean firm strike emissions swap deal: Companies make carbon credit trade
• Abstracts: Is the nursing work index measuring up?: Moving beyond estimating reliability to testing validity. Influence of organizational characterstics and context on research utilization
• Abstracts: Capital spending leaves First Calgary in red. Shiningbank, Rider kill plan to merge operations

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.